Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aytu Bioscience Inc (AYTUD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16,669
  • Shares Outstanding, K 4,220
  • Annual Sales, $ 3,220 K
  • Annual Income, $ -22,510 K
  • 36-Month Beta 5.21
  • Price/Sales 4.98
  • Price/Cash Flow N/A
  • Price/Book 0.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -48.16
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/06/17
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.3400 +22.75%
on 08/28/17
4.5000 -8.89%
on 09/14/17
-0.2000 (-4.65%)
since 08/25/17
3-Month
3.3400 +22.75%
on 08/28/17
12.0000 -65.83%
on 07/28/17
-7.6000 (-64.96%)
since 06/27/17
52-Week
3.3400 +22.75%
on 08/28/17
77.8000 -94.73%
on 10/04/16
-62.9000 (-93.88%)
since 09/27/16

Most Recent Stories

More News
Today's Research Reports on Stocks to Watch: Corbus Pharmaceuticals and Aytu Bioscience

NEW YORK, NY / ACCESSWIRE / September 21, 2018 / Biotech stocks Corbus Pharmaceuticals and Aytu BiosScience were both roaring on Thursday. Shares of Corbus exploded on the news that it has expanded its...

CRBP : 6.70 (-15.72%)
AYTUD : 4.1000 (+3.80%)
Natesto(R) Q4 Revenue Increases 178% Sequentially; Q4 Product Revenue Increases 52% Sequentially

AYTUD : 4.1000 (+3.80%)
LPBC : 11.9500 (-0.42%)
AYTU : 2.89 (-14.87%)
Aytu BioScience to Report Fiscal Fourth Quarter 2018 Results and Business Update

Live Conference Call and Webcast Scheduled for September 6, 2018, at 4:30 p.m. ET

AYTUD : 4.1000 (+3.80%)
AYTU : 2.89 (-14.87%)
Aytu BioScience Announces Accelerated Launch of ZolpiMis(TM) in the U.S.

ZolpiMist Launches into the $1.8 billion U.S. Non-Benzodiazepine Prescription Sleep Aid Market

AYTUD : 4.1000 (+3.80%)
AYTU : 2.89 (-14.87%)
Aytu BioScience Announces Effectiveness of 1-for-20 Reverse Stock Split

ENGLEWOOD, CO / ACCESSWIRE / August 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant medical...

AYTUD : 4.1000 (+3.80%)
AYTU : 2.89 (-14.87%)
Aytu BioScience Announces 7 Presentations of Clinical Findings for its Proprietary MiOXSYS(R) System at the 34th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE)

- Multi-Center, Global Study Demonstrates that MiOXSYS Provides an Accurate Measure of Seminal Oxidative Stress that can be Standardized Globally Within Clinical Andrology and IVF Laboratories

AYTUD : 4.1000 (+3.80%)
AYTU : 2.89 (-14.87%)
Aytu BioScience Enters $1.8 Billion U.S. Prescription Sleep Aid Market with Exclusive License to Zolpimist(TM) to Expand Company's Commercial-Stage Product Portfolio

Company Acquires FDA-Approved, Commercial-Stage Product to Complement Natesto® Sales Efforts Among Primary Care Physicians

AYTUD : 4.1000 (+3.80%)
AYTU : 2.89 (-14.87%)
Aytu BioScience Provides Fiscal Third Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET

Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of its business, including...

AYTUD : 4.1000 (+3.80%)
LPBC : 11.9500 (-0.42%)
AYTU : 2.89 (-14.87%)
Aytu BioScience CEO Issues Letter to Shareholders

ENGLEWOOD, CO / ACCESSWIRE / May 8, 2018 / (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, has highlighted its progress...

AYTUD : 4.1000 (+3.80%)
AYTU : 2.89 (-14.87%)
Aytu BioScience to Report Fiscal Third Quarter 2018 Results and Business Update

Live Conference Call and Webcast Scheduled for May 14, 2018, at 4:30 p.m. ET

AYTUD : 4.1000 (+3.80%)
AYTU : 2.89 (-14.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AYTUD with:

Key Turning Points

2nd Resistance Point 4.2200
1st Resistance Point 4.1600
Last Price 4.1000
1st Support Level 4.0200
2nd Support Level 3.9400

See More

52-Week High 77.8000
Fibonacci 61.8% 49.3563
Fibonacci 50% 40.5700
Fibonacci 38.2% 31.7837
Last Price 4.1000
52-Week Low 3.3400

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar